<DOC>
	<DOCNO>NCT02204436</DOCNO>
	<brief_summary>Aim study evaluate instrumental measurement depigmenting activity cosmetic treatment spot hand skin ; particular investigate synergic activity emulsion , clarifying-antioxidant activity combine activator gel , hydration keratolytic activity . Female healthy volunteer age 45-65 year old , present senile lentigo hand , include study . It also aim study evaluate treatment efficacy cosmetic acceptability volunteer tolerance investigator volunteer .</brief_summary>
	<brief_title>Clinical Study Evaluation Depigmenting Activity Cosmetic Product Spotted Hand Skin</brief_title>
	<detailed_description>The following instrumental evaluation perform basal condition ( T0 - product use ) , 4 ( T4 ) 8 week-treatment ( T8 ) : - Image analysis UV flash ( Wood 's light ) - Photographic recovery - Skin spot image analysis - Skin colour evaluation - Spectrophotometry ( skin brightness ) - Optical colorimetry ( spot colour ) At end study ( T8 ) , volunteer fill questionnaire regarding : - efficacy study product ( skin brightness hydration , spots dimension colour intensity - score : mark ; mark ; medium ; light ; absent ) - cosmetic acceptability study product : colour perfume application , consistency , spreadability , absorption , effect skin , greasiness presence product residue ( score : negative ; medium ; good ; excellent ) product tolerance ( score : bad ; poor ; medium ; good ; excellent ) . At end study investigator assess treatment tolerance consider possible appearance related adverse event bad , poor , medium , good , excellent .</detailed_description>
	<criteria>female healthy subject age 4565 year presence moderate senile lentigo back hand accept receive drugs/cosmetic/chemical physical treatment ( peel , intradermal implant etc . ) able change skin characteristic entire duration study accept use study product accord instruction receive investigator accept expose strong UV irradiation ( UV session , sun bathe ) entire duration study subject agree use antispots products/treatments month precede test accept sign Informed Consent Form pregnancy lactation sensitivity test product ingredient subject whose insufficient adhesion study protocol foreseeable participation similar study actually previous 3 month dermatological disease ( dermatitis ; presence cutaneous disease test area , lesion , scar , malformation ) clinical significant skin condition test area ( e.g . active eczema , dermatitis , psoriasis . etc . ) diabetes endocrine disease hepatic disorder renal disorder cardiac disorder pulmonary disease cancer neurological psychological disease inflammatory/immunosuppressive disease drug allergy systemic corticosteroid aspirin nonsteroid antiinflammatory drug ( FANS ) antihistaminic , narcotic , antidepressant , immunosuppressive drug ( except contraceptive hormonal treatment start least 1 year ) assumption drug able influence test result investigator opinion</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>hyperpigmentation</keyword>
	<keyword>depigmenting treatment</keyword>
	<keyword>hand</keyword>
</DOC>